New Delhi:The Coldrif cough syrup scandal, which claimed the lives of children in Madhya Pradesh, has now blown the lid off deep regulatory failures by the Tamil Nadu Food and Drug Administration (TNFDA). Investigations by the Central Drugs Standard Control Organisation (CDSCO) have revealed that Sresan Pharma, the Kanchipuram-based manufacturer of the cough syrup, operated unchecked for over a decade despite its dismal infrastructure and multiple violations of national drug safety rules, the CDSCO sources told PTI. Shockingly, a source says the company, licensed in 2011 by the TNFDA, was never part of any of the CDSCO databases. The CDSCO's inspection exposed the unit's appalling conditions and total non-compliance with Good Manufacturing Practices (GMP), the sources said.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!